Superdisintegrants Market Share, Competitive Landscape, and Industry Outlook
Market Overview
The global Superdisintegrants Market is projected to grow from USD 387.13 million in 2021 to USD 653.99 million by 2028 at a CAGR of around 7.72% during the forecast period of 2022-2028. The market growth is primarily driven by the increasing use of orally disintegrating tablets, expanding geriatric populace, rising prevalence of chronic diseases, and growing focus on R&D activities for new drug development.
The report highlights key insights related to Superdisintegrants Market size, trends and future market growth and forecast, along with competitive landscape and emerging opportunities. It is designed to help stakeholders understand market direction and make data-driven decisions.
Industry stakeholders are closely evaluating the Superdisintegrants Market size analysis to identify opportunities associated with expanding pharmaceutical manufacturing and increasing chronic disease prevalence. Rising healthcare expenditure and growing preference for patient-friendly dosage forms continue to strengthen market demand. Furthermore, advancements in excipient technologies and formulation science are supporting the development of highly efficient disintegration solutions for modern drug delivery systems globally.
What is Superdisintegrants Market?
Superdisintegrants are substances included within tablet formulations to assist in the break-up of the compacted mass into primary particles to facilitate dissolution. Based on product type, superdisintegrants are categorized as croscarmellose sodium, crospovidone, sodium starch glycolate, ion exchange resins, and others.
These ingredients are widely used in pharmaceutical formulations to improve tablet disintegration and enhance drug release efficiency. Superdisintegrants play a significant role in orally disintegrating tablets and advanced drug delivery systems.
Market Growth Drivers
The Superdisintegrants Market is witnessing strong growth due to rising demand for orally disintegrating tablets and expanding pharmaceutical research activities.
Major growth drivers include:
• Increasing use of orally disintegrating tablets.
• Expanding geriatric populace.
• Rising prevalence of chronic diseases.
• Growing focus on R&D activities for new drug development.
• Increasing healthcare awareness and pharmaceutical advancements.
• Rising demand for improved patient-friendly drug formulations.
The tablet formulation segment accounted for the largest market share in 2021 and is expected to register significant growth during the review period due to increasing consumption of orally disintegrating tablets across geographies.
Get the free sample of the link:
“https://www.stratviewresearch.com/Request-Sample/Superdisintegrants-Market#form”
Key Challenges
The COVID-19 outbreak posed significant challenges across industries worldwide and negatively impacted the growth of the Superdisintegrants Market. Supply disruptions affected product availability in the market, creating operational and distribution challenges for pharmaceutical manufacturers.
Additionally, fluctuations in raw material supply chains and strict pharmaceutical regulatory requirements continue to remain important concerns for market participants.
Market Segmentation
The Superdisintegrants Market is segmented based on product, formulation, therapeutic area, and region.
By Product
• Croscarmellose Sodium
• Crospovidone
• Sodium Starch Glycolate
• Ion Exchange Resins
• Other
By Formulation
• Tablet
• Capsules
The tablet segment accounted for the largest market share in 2021 due to increasing demand for orally disintegrating tablets.
By Therapeutic Area
• Oncology
• Neurology
• Cardiology
• Infectious Diseases
Regional Analysis
The market is segmented into the following regions:
• North America
• Asia-Pacific
North America accounted for the largest market share in 2021 and is projected to grow at a robust CAGR during the review period. This growth is attributed to increasing investment in R&D activities for new drug development, expanding geriatric populace, and the presence of key players such as FMC Corporation (US) and Ashland Global Specialty Chemicals Inc. (US).
Asia-Pacific is expected to witness strong growth due to increasing spending on healthcare, rising health consciousness, and increasing per capita disposable income among consumers.
Key Companies
The following are the key players operating in the Superdisintegrants Market:
• Ashland Global Specialty Chemicals Inc. (US)
• BASF SE (Germany)
• FMC Corporation (US)
• JRS Pharma (Germany)
• DFE Pharma (Germany)
• Roquette (France)
• Dow (US)
• Asahi Kasei Corporation (Japan)
• Nippon Soda (Japan)
• J.M. Huber Corporation (US)
These companies are focusing on research activities, product innovation, and pharmaceutical collaborations to strengthen their market presence globally.
FAQ
What is the projected size of the Superdisintegrants Market by 2028?
The market is projected to reach USD 653.99 million by 2028.
What is the CAGR of the Superdisintegrants Market?
The market is expected to grow at a CAGR of around 7.72% during 2022-2028.
Which formulation segment dominates the market?
The tablet segment accounted for the largest market share in 2021.
Which region accounted for the largest market share?
North America accounted for the largest market share in 2021.
Conclusion
The Superdisintegrants Market is expected to witness substantial growth due to increasing demand for orally disintegrating tablets, growing chronic disease prevalence, and expanding pharmaceutical R&D activities. The tablet segment remains dominant owing to rising consumption of fast-disintegrating formulations worldwide. North America continues to lead the market because of strong pharmaceutical infrastructure and the presence of major industry participants. Increasing healthcare spending and rising awareness in Asia-Pacific are also expected to create new growth opportunities during the forecast period.
